Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection
- PMID: 38830902
- PMCID: PMC11148197
- DOI: 10.1038/s41598-024-59634-y
Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection
Erratum in
-
Author Correction: Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection.Sci Rep. 2024 Jul 10;14(1):15918. doi: 10.1038/s41598-024-66711-9. Sci Rep. 2024. PMID: 38987550 Free PMC article. No abstract available.
Abstract
Humoral immunity in COVID-19 includes antibodies (Abs) targeting spike (S) and nucleocapsid (N) SARS-CoV-2 proteins. Antibody levels are known to correlate with disease severity, but titers are poorly reported in mild or asymptomatic cases. Here, we analyzed the titers of IgA and IgG against SARS-CoV-2 proteins in samples from 200 unvaccinated Hospital Workers (HWs) with mild COVID-19 at two time points after infection. We analyzed the relationship between Ab titers and patient characteristics, clinical features, and evolution over time. Significant differences in IgG and IgA titers against N, S1 and S2 proteins were found when samples were segregated according to time T1 after infection, seroprevalence at T1, sex and age of HWs and symptoms at infection. We found that IgM + samples had higher titers of IgG against N antigen and IgA against S1 and S2 antigens than IgM - samples. There were significant correlations between anti-S1 and S2 Abs. Interestingly, IgM + patients with dyspnea had lower titers of IgG and IgA against N, S1 and S2 than those without dyspnea. Comparing T1 and T2, we found that IgA against N, S1 and S2 but only IgG against certain Ag decreased significantly. In conclusion, an association was established between Ab titers and the development of infection symptoms.
Keywords: COVID-19; IgA; IgG; SARS-CoV-2; Seroprevalence.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.J Clin Microbiol. 2021 Apr 20;59(5):e02890-20. doi: 10.1128/JCM.02890-20. Print 2021 Apr 20. J Clin Microbiol. 2021. PMID: 33602698 Free PMC article.
-
A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.J Infect Dis. 2021 Jul 15;224(2):218-228. doi: 10.1093/infdis/jiab222. J Infect Dis. 2021. PMID: 33905505 Free PMC article.
-
Humoral response to spike S1 and S2 and nucleocapsid proteins on microarray after SARS-CoV-2 infection.J Med Virol. 2022 Jan;94(1):178-185. doi: 10.1002/jmv.27290. Epub 2021 Aug 26. J Med Virol. 2022. PMID: 34428312 Free PMC article.
-
Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers.Int Immunopharmacol. 2022 Feb;103:108491. doi: 10.1016/j.intimp.2021.108491. Epub 2021 Dec 21. Int Immunopharmacol. 2022. PMID: 34954559 Free PMC article.
-
Potential Usefulness of IgA for the Early Detection of SARS-CoV-2 Infection: Comparison With IgM.Pol J Microbiol. 2024 Jun 20;73(2):123-130. doi: 10.33073/pjm-2024-019. eCollection 2024 Jun 1. Pol J Microbiol. 2024. PMID: 38905276 Free PMC article. Review.
Cited by
-
Serological response after COVID-19 infection compared to vaccination against COVID-19 in children with autoimmune rheumatic diseases.Pediatr Rheumatol Online J. 2024 Jul 25;22(1):68. doi: 10.1186/s12969-024-01003-0. Pediatr Rheumatol Online J. 2024. PMID: 39054538 Free PMC article.
-
Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality.Vaccines (Basel). 2025 Jul 2;13(7):723. doi: 10.3390/vaccines13070723. Vaccines (Basel). 2025. PMID: 40733700 Free PMC article. Review.
-
Individuals Infected with SARS-CoV-2 Prior to COVID-19 Vaccination Maintain Vaccine-Induced RBD-Specific Antibody Levels and Viral Neutralization Activity for One Year.Viruses. 2025 Apr 29;17(5):640. doi: 10.3390/v17050640. Viruses. 2025. PMID: 40431652 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous